COVID-19 vaccination programme
GPTKB entity
Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_policy
|
| gptkbp:aimsTo |
controlling COVID-19 pandemic
|
| gptkbp:beganIn |
December 2020
|
| gptkbp:challenge |
vaccine hesitancy
vaccine supply shortages logistical issues cold chain requirements inequitable distribution |
| gptkbp:communication |
community outreach
social media campaigns media campaigns public service announcements |
| gptkbp:coordinates |
gptkb:World_Health_Organization
national governments |
| gptkbp:dataCollected |
adverse events
vaccine effectiveness vaccine coverage rates breakthrough infection rates |
| gptkbp:deliveryMethods |
pharmacies
primary care clinics mass vaccination sites mobile vaccination units |
| gptkbp:fundedBy |
gptkb:government
international organizations governments |
| gptkbp:goal |
achieve herd immunity
|
| https://www.w3.org/2000/01/rdf-schema#label |
COVID-19 vaccination programme
|
| gptkbp:monitors |
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:European_Medicines_Agency public health agencies national health ministries |
| gptkbp:priorityGroups |
elderly
healthcare workers people with underlying health conditions |
| gptkbp:relatedTo |
gptkb:COVID-19_pandemic
vaccine mandates vaccine passports booster doses COVAX initiative |
| gptkbp:result |
reduced COVID-19 mortality
reduced COVID-19 transmission reduced hospitalization rates emergence of breakthrough infections |
| gptkbp:targetAudience |
general public
|
| gptkbp:vaccineType |
gptkb:Johnson_&_Johnson_COVID-19_vaccine
gptkb:Moderna_COVID-19_vaccine gptkb:Pfizer-BioNTech_COVID-19_vaccine gptkb:Sinovac_COVID-19_vaccine gptkb:Sputnik_V_COVID-19_vaccine Oxford-AstraZeneca COVID-19 vaccine |
| gptkbp:bfsParent |
gptkb:NHS_COVID_Pass
|
| gptkbp:bfsLayer |
6
|